Show simple item record

dc.contributor.advisorMichael E. Birnbaum.en_US
dc.contributor.authorRappazzo, Charles Garrett.en_US
dc.contributor.otherMassachusetts Institute of Technology. Department of Biological Engineering.en_US
dc.date.accessioned2020-10-08T21:28:53Z
dc.date.available2020-10-08T21:28:53Z
dc.date.copyright2020en_US
dc.date.issued2020en_US
dc.identifier.urihttps://hdl.handle.net/1721.1/127887
dc.descriptionThesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, May, 2020en_US
dc.descriptionCataloged from PDF version of thesis.en_US
dc.descriptionIncludes bibliographical references.en_US
dc.description.abstractT cells occupy essential roles throughout the immune system to prevent and limit disease. As such, breakdowns in their function and recognition underlie poor clinical outcomes across diverse maladies including pathogen infection, cancer, autoimmunity, allergies, and transplant rejection. Yet, when properly directed, T cells drive potent protective and therapeutic responses in prophylactic vaccinations and novel immunotherapies. Therefore, understanding and harnessing T cell function and recognition is of great importance to improving patient care and addressing currently unmet clinical needs. The function and recognition of T cells are driven through their T cell receptors (TCRs), which bind with great specificity to peptide-MHCs (pMHCs), Major Histocompatibility Complex proteins displaying tissue- and disease-specific peptide antigens derived from their host cell or its surroundings.en_US
dc.description.abstractHowever, to specifically and comprehensively present and surveil antigens across highly divergent maladies, extreme diversity is required of both the population-level TCR and pMHC repertoires. However, this same diversity which drives T cell function also confounds generalized understanding of these repertoires, as well as their recognition. Therefore, there has been considerable recent interest in the development and application of tools to comprehensively define, predict, and screen these repertoires and their recognition at high throughput. In this thesis, I both utilize and build upon these tools to define TCR and pMHC repertoires and explore their recognition, particularly with yeast-displayed pMHC libraries for CD4⁺ T cell recognition of class II pMHCs, and especially in the context of cancer.en_US
dc.description.abstractUsing these technologies, I empirically define pMHC repertoires, explore the antigenic basis of TCR repertoire convergence in a preclinical tumor model, and explore the antigen reactivity of human T cells with clinical relevance. While these results provide detailed insights into the specific TCRs and pMHCs studied, they also provide guidance for future avenues in the exploration of TCR and pMHC repertoires and their recognition.en_US
dc.description.statementofresponsibilityby Charles Garrett Rappazzo.en_US
dc.format.extent98 pagesen_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsMIT theses may be protected by copyright. Please reuse MIT thesis content according to the MIT Libraries Permissions Policy, which is available through the URL provided.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectBiological Engineering.en_US
dc.titleDetermination of class II peptide-MHC repertoires and recognition via large yeast-displayed librariesen_US
dc.typeThesisen_US
dc.description.degreePh. D.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.identifier.oclc1197071798en_US
dc.description.collectionPh.D. Massachusetts Institute of Technology, Department of Biological Engineeringen_US
dspace.imported2020-10-08T21:28:52Zen_US
mit.thesis.degreeDoctoralen_US
mit.thesis.departmentBioEngen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record